Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging (Q30835804)

27 June 2017

Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging (English)

1 reference

27 June 2017

0 references

1 reference

Xavier Golay

5

0 references

Klaas Nicolay

object named as

Klaas Nicolay

6

0 references

Frederik Barkhof

2

object named as

Frederik Barkhof

1 reference

27 June 2017

4

Nicola De Stefano

1 reference

27 June 2017

13

David H Miller

1 reference

27 June 2017

8

Petra J W Pouwels

1 reference

27 June 2017

9

Seth A Smith

1 reference

27 June 2017

Olga Ciccarelli

1

1 reference

27 June 2017

Benedetta Bodini

3

1 reference

27 June 2017

Daniel Pelletier

7

1 reference

27 June 2017

Claudia A M Wheeler-Kingshott

10

1 reference

27 June 2017

Bruno Stankoff

11

1 reference

27 June 2017

Tarek Yousry

12

1 reference

27 June 2017

6 July 2014

1 reference

27 June 2017

1 reference

27 June 2017

13

1 reference

27 June 2017

8

1 reference

27 June 2017

807-822

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

27 June 2017

1 reference

7 January 2021

The future of immunoimaging--deeper, bigger, more precise, and definitively more colorful.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

New approaches to neuroimaging of central nervous system inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Towards molecular imaging of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

CEST: from basic principles to applications, challenges and opportunities.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Energy failure in multiple sclerosis and its investigation using MR techniques

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

The role of mitochondria in axonal degeneration and tissue repair in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Noninvasive molecular imaging of neuroinflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Systemic inflammatory response reactivates immune-mediated lesions in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Magnetic resonance imaging of monocytes labeled with ultrasmall superparamagnetic particles of iron oxide using magnetoelectroporation in an animal model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

PET visualization of microglia in multiple sclerosis patients using [11C]PK11195

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Increased PK11195 PET binding in the cortex of patients with MS correlates with disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Translocator protein PET imaging for glial activation in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Reversible decreases in N-acetylaspartate after acute brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Spinal cord repair in MS: does mitochondrial metabolism play a role?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: a cross-sectional 23Na MR imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Development of chemical exchange saturation transfer at 7 T

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Imaging of glutamate neurotransmitter alterations in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Magnetic resonance imaging of glutamate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Probes for non-invasive matrix metalloproteinase-targeted imaging with PET and SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Myelin imaging compound (MIC) enhanced magnetic resonance imaging of myelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Synthesis and characterization of a novel gadolinium-based contrast agent for magnetic resonance imaging of myelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

MICEST: a potential tool for non-invasive detection of molecular changes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

In vivo mapping of brain myo-inositol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Will the real multiple sclerosis please stand up?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

2-photon imaging of phagocyte-mediated T cell activation in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Dynamics and fate of USPIO in the central nervous system in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

B cells and antibodies in multiple sclerosis pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

18F-ML-10, a PET tracer for apoptosis: first human study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

(99m)Tc-labeled rituximab for imaging B lymphocyte infiltration in inflammatory autoimmune disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Microglia in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Axonal conduction and injury in multiple sclerosis: the role of sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Molecular imaging of microglia/macrophages in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Mixed-affinity binding in humans with 18-kDa translocator protein ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Progressive multiple sclerosis: pathology and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Mechanisms of white matter damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Combined 1H and 31P spectroscopy provides new insights into the pathobiochemistry of brain damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Assessing neuronal metabolism in vivo by modeling imaging measures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Imaging correlates of axonal swelling in chronic multiple sclerosis brains.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Multiple sclerosis normal-appearing white matter: pathology-imaging correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Electron microscopic features of multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Acid-sensing ion channels in pain and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

MRI assessment of iron deposition in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Microglial physiology: unique stimuli, specialized responses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Glutamatergic signaling in the brain's white matter.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Imaging of CNS myelin by positron-emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Remyelination protects axons from demyelination-associated axon degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Remyelination in the CNS: from biology to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Longitudinal positron emission tomography imaging for monitoring myelin repair in the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Cellular mechanisms of brain energy metabolism. Relevance to functional brain imaging and to neurodegenerative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

18F-FDG PET detects inflammatory infiltrates in spinal cord experimental autoimmune encephalomyelitis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Myelination: do astrocytes play a role?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Multinuclear NMR studies on the energy metabolism of glial and neuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970101-2

7 January 2021

10.1016/S1474-4422(14)70101-2

Identifiers

DOI

1 reference

27 June 2017

1 reference